Niktimvo

Active Ingredient(s): Axatilimab-csfr
FDA Approved: * August 14, 2024
Pharm Company: * INCYTE CORP
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Niktimvo 50 mg/ml Intravenous Injection
NDC: 50881-012
Labeler:
Incyte Corporation